In breast cancer cells, PD-L1 recruits β4 integrin at the cell rear to engage with cytoskeleton remodeling and RhoA activation, thereby facilitating rear retraction and supporting the release of PD-L1-containing migrasomes, which likely dampen antitumor immunity [243]. This evidence concerns the gene CD274 and breast cancer.